James Molloy
Stock Analyst at Alliance Global Partners
(0.03)
# 4,883
Out of 5,133 analysts
284
Total ratings
19.2%
Success rate
-29.1%
Average return
Main Sectors:
Stocks Rated by James Molloy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMNN Imunon | Reiterated: Buy | $12 → $6 | $0.629 | +853.90% | 7 | Nov 13, 2026 | |
| PTHS Pelthos Therapeutics | Downgraded: Hold | n/a | $7.44 | - | 51 | Nov 13, 2026 | |
| TNXP Tonix Pharmaceuticals Holding | Reiterated: Buy | $65 → $40 | $3.01 | +1,228.90% | 43 | Nov 9, 2026 | |
| ACXP Acurx Pharmaceuticals | Reiterated: Buy | $10 | $0.96 | +941.67% | 6 | Sep 29, 2026 | |
| QNRX Quoin Pharmaceuticals | Reiterated: Buy | $35 | $3.70 | +845.95% | 5 | Aug 17, 2026 | |
| INTS Intensity Therapeutics | Reiterated: Buy | $30 → $15 | $3.08 | +387.01% | 7 | Aug 11, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | $9 | $3.98 | +126.13% | 7 | Aug 7, 2026 | |
| SNGX Soligenix | Reiterated: Buy | $1.5 | $0.321 | +367.29% | 11 | Aug 7, 2026 | |
| AZR Azora Therapeutics | Initiated Coverage: Buy | $11 | $4.09 | +168.95% | 1 | Aug 3, 2026 | |
| SLS SELLAS Life Sciences Group | Reiterated: Buy | $10 → $25 | $7.86 | +218.07% | 10 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $8.18 | +120.05% | 8 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $1.97 | +813.71% | 1 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.23 | +387.80% | 3 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $0.35326 | +8,392.33% | 7 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.831 | +622.02% | 10 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $3.91 | +130.18% | 8 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 | $0.906 | +286.31% | 4 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $19.69 | +179.33% | 6 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $2.42 | +726.45% | 7 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.1441 | +2,675.85% | 6 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.05 | +566.67% | 6 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4.5 | $0.8726 | +415.70% | 8 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $1.69 | +8,775.74% | 4 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $280 | $6.80 | +4,017.65% | 4 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $213 | $1.71 | n/a | 4 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 → $84 | $2.89 | n/a | 2 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $4.5 | $1.42 | n/a | 3 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $490 | $1.43 | n/a | 3 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.5 | $2.08 | n/a | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3.5 | $0.176 | n/a | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $5.78 | n/a | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7.2 | $0.1895 | n/a | 1 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $0.5941 | n/a | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $1.04 | n/a | 1 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.75 → $3.5 | $0.1436 | n/a | 2 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.5 | $0.000001 | n/a | 1 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $80 | $0.1141 | n/a | 1 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $63 → $7 | $1.52 | n/a | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $80 | $2.16 | n/a | 1 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $0.6301 | n/a | 1 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.1831 | n/a | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $4 | $1.05 | n/a | 2 | Jul 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $2.61 | n/a | 1 | Jul 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $16 | $0.0002 | n/a | 6 | Mar 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $40 | $3.71 | n/a | 2 | Nov 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6.5 → $11 | $0.000001 | n/a | 2 | Apr 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $35 | $0.0003 | n/a | 1 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $6.26 | n/a | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $1.65 | n/a | 1 | Jul 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $0.0708 | n/a | 1 | Oct 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $30 | $1.18 | n/a | 3 | Jun 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $1.30 | n/a | 1 | Sep 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $7.03 | n/a | 1 | Jan 27, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $35 | $5.79 | n/a | 1 | May 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $21.38 | n/a | 1 | Nov 13, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $4.83 | n/a | 1 | Jul 24, 2013 |
Imunon
Nov 13, 2026
Reiterated: Buy
Price Target: $12 → $6
Current: $0.629
Upside: +853.90%
Pelthos Therapeutics
Nov 13, 2026
Downgraded: Hold
Price Target: n/a
Current: $7.44
Upside: -
Tonix Pharmaceuticals Holding
Nov 9, 2026
Reiterated: Buy
Price Target: $65 → $40
Current: $3.01
Upside: +1,228.90%
Acurx Pharmaceuticals
Sep 29, 2026
Reiterated: Buy
Price Target: $10
Current: $0.96
Upside: +941.67%
Quoin Pharmaceuticals
Aug 17, 2026
Reiterated: Buy
Price Target: $35
Current: $3.70
Upside: +845.95%
Intensity Therapeutics
Aug 11, 2026
Reiterated: Buy
Price Target: $30 → $15
Current: $3.08
Upside: +387.01%
Opus Genetics
Aug 7, 2026
Reiterated: Buy
Price Target: $9
Current: $3.98
Upside: +126.13%
Soligenix
Aug 7, 2026
Reiterated: Buy
Price Target: $1.5
Current: $0.321
Upside: +367.29%
Azora Therapeutics
Aug 3, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $4.09
Upside: +168.95%
SELLAS Life Sciences Group
Jul 6, 2026
Reiterated: Buy
Price Target: $10 → $25
Current: $7.86
Upside: +218.07%
Jun 24, 2026
Reiterated: Buy
Price Target: $18
Current: $8.18
Upside: +120.05%
Jun 8, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $1.97
Upside: +813.71%
May 26, 2026
Reiterated: Buy
Price Target: $6
Current: $1.23
Upside: +387.80%
May 21, 2026
Reiterated: Buy
Price Target: $30
Current: $0.35326
Upside: +8,392.33%
May 18, 2026
Reiterated: Buy
Price Target: $6
Current: $0.831
Upside: +622.02%
May 14, 2026
Reiterated: Buy
Price Target: $9
Current: $3.91
Upside: +130.18%
May 14, 2026
Reiterated: Buy
Price Target: $3.5
Current: $0.906
Upside: +286.31%
May 14, 2026
Reiterated: Buy
Price Target: $55
Current: $19.69
Upside: +179.33%
May 13, 2026
Reiterated: Buy
Price Target: $20
Current: $2.42
Upside: +726.45%
May 6, 2026
Reiterated: Buy
Price Target: $4
Current: $0.1441
Upside: +2,675.85%
Apr 6, 2026
Reiterated: Buy
Price Target: $7
Current: $1.05
Upside: +566.67%
Apr 2, 2026
Reiterated: Buy
Price Target: $4.5
Current: $0.8726
Upside: +415.70%
Feb 19, 2026
Reiterated: Buy
Price Target: $150
Current: $1.69
Upside: +8,775.74%
Nov 19, 2025
Reiterated: Buy
Price Target: $280
Current: $6.80
Upside: +4,017.65%
Jun 17, 2025
Reiterated: Buy
Price Target: $213
Current: $1.71
Upside: n/a
May 22, 2025
Reiterated: Buy
Price Target: $200 → $84
Current: $2.89
Upside: n/a
Apr 15, 2025
Reiterated: Buy
Price Target: $12 → $4.5
Current: $1.42
Upside: n/a
Jan 27, 2025
Reiterated: Buy
Price Target: $490
Current: $1.43
Upside: n/a
Aug 13, 2024
Reiterated: Buy
Price Target: $7.5
Current: $2.08
Upside: n/a
Jul 17, 2024
Initiated Coverage: Buy
Price Target: $3.5
Current: $0.176
Upside: n/a
Jul 17, 2024
Initiated Coverage: Buy
Price Target: $10
Current: $5.78
Upside: n/a
May 2, 2024
Initiated Coverage: Buy
Price Target: $7.2
Current: $0.1895
Upside: n/a
Mar 7, 2024
Reiterated: Buy
Price Target: $11
Current: $0.5941
Upside: n/a
Dec 11, 2023
Initiated Coverage: Buy
Price Target: $30
Current: $1.04
Upside: n/a
May 31, 2023
Reiterated: Buy
Price Target: $2.75 → $3.5
Current: $0.1436
Upside: n/a
Mar 6, 2023
Initiated Coverage: Buy
Price Target: $5.5
Current: $0.000001
Upside: n/a
Jan 23, 2023
Initiated Coverage: Buy
Price Target: $80
Current: $0.1141
Upside: n/a
Nov 17, 2022
Reiterated: Buy
Price Target: $63 → $7
Current: $1.52
Upside: n/a
Oct 20, 2022
Initiated Coverage: Buy
Price Target: $80
Current: $2.16
Upside: n/a
Aug 25, 2022
Initiated Coverage: Buy
Price Target: $15
Current: $0.6301
Upside: n/a
Aug 5, 2022
Downgraded: Hold
Price Target: n/a
Current: $0.1831
Upside: n/a
Jul 20, 2022
Reiterated: Buy
Price Target: $13 → $4
Current: $1.05
Upside: n/a
Jul 5, 2022
Initiated Coverage: Buy
Price Target: n/a
Current: $2.61
Upside: n/a
Mar 15, 2022
Reiterated: Buy
Price Target: $20 → $16
Current: $0.0002
Upside: n/a
Nov 9, 2021
Reiterated: Buy
Price Target: $25 → $40
Current: $3.71
Upside: n/a
Apr 15, 2021
Reiterated: Buy
Price Target: $6.5 → $11
Current: $0.000001
Upside: n/a
Jan 21, 2021
Initiated Coverage: Buy
Price Target: $35
Current: $0.0003
Upside: n/a
Aug 10, 2020
Initiated Coverage: Buy
Price Target: $27
Current: $6.26
Upside: n/a
Jul 13, 2020
Initiated Coverage: Buy
Price Target: $11
Current: $1.65
Upside: n/a
Oct 8, 2018
Initiated Coverage: Buy
Price Target: $50
Current: $0.0708
Upside: n/a
Jun 30, 2017
Reiterated: Buy
Price Target: $35 → $30
Current: $1.18
Upside: n/a
Sep 6, 2016
Initiated Coverage: Buy
Price Target: $20
Current: $1.30
Upside: n/a
Jan 27, 2015
Reiterated: Buy
Price Target: $25
Current: $7.03
Upside: n/a
May 15, 2014
Initiated Coverage: Buy
Price Target: $35
Current: $5.79
Upside: n/a
Nov 13, 2013
Initiated Coverage: Buy
Price Target: $30
Current: $21.38
Upside: n/a
Jul 24, 2013
Upgraded: Buy
Price Target: n/a
Current: $4.83
Upside: n/a